CERS logo

Cerus Corporation (CERS)

Profile

Full Name

Cerus Corporation

Ticker

NASDAQ: CERS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

January 31, 1997

Indexes

Not included

Website

https://www.cerus.com

Employees

614

Key Details

Price

$2.18(1.40%)

Market Cap

$418.75M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$180.27M(15.29% YoY)

Annual EPS

-$0.11(45.53% YoY)

PE Ratio

-

Next earnings date

Feb 19, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.18
    CERS price is $2.18

    30-Day Relative Volume

    1.65
    CERS 30-day relative volume is 1.65

    Price Performance

    Price Most Recent Change

    +1.4%
    CERS price was up +1.4% on Dec 12, 2025

    Price YTD Change

    +41.56%
    CERS price is up +41.56% since January 1st

    Price 1-Year Change

    +22.47%
    CERS price is up +22.47% year-on-year

    Price 3-Year Change

    -42.63%
    CERS price is down -42.63% over the past 3 years

    Price Range

    Price All-Time High

    $81.88
    CERS price is currently -97.34% below its historical high of $81.88

    Price 3-Year Low

    $1.12
    CERS price is currently +94.64% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $418.75M
    CERS market cap is $418.75 million

    Market Cap 3-Year Change

    -37.89%
    CERS market cap is down -37.89% over the past 3 years

    Market Cap All-Time High

    $1.43B
    CERS market cap is currently -70.73% below its historical high of $1.43 billion

    Market Cap Sector Percentile

    59.24%
    CERS market cap is higher than 59.24% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.43%
    CERS shares outstanding is up +3.43% year-on-year

    Shares Outstanding 3-Year Change

    +8.27%
    CERS shares outstanding is up +8.27% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.67
    CERS beta is 1.67

    200-day SMA

    $1.44
    CERS price is currently +51.48% above its 200-day simple moving average

    50-day SMA

    $1.66
    CERS price is currently +31.64% above its 50-day simple moving average

    14-Day RSI

    69.62
    CERS 14-day relative strength index is 69.62

    Volume

    1.65
    CERS 30-day relative volume is 1.65

    ATR

    $0.13
    CERS average true range is $0.13

    10-day Historical Volatility

    95.76%
    CERS 10-day historical volatility is 95.76%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $180.27M
    CERS annual revenue is $180.27 million

    Revenue Analysts Estimate

    $211.93M
    CERS annual revenue is currently -14.94% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +15.29%
    CERS annual revenue is up +15.29% year-on-year

    Revenue Sector Percentile

    72.89%
    CERS annual revenue is higher than 72.89% of companies in Healthcare sector

    EPS

    EPS

    -$0.11
    CERS annual earnings per share is -$0.11

    EPS Analysts Estimate

    -$0.08
    CERS annual earnings per share is currently -41.63% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +45.53%
    CERS annual earnings per share is up +45.53% year-on-year

    EPS Sector Percentile

    78.07%
    CERS annual earnings per share is higher than 78.07% of companies in Healthcare sector

    Profit

    Gross Profit

    $97.52M
    CERS annual gross profit is $97.52 million

    Gross Margin

    54.10%
    CERS annual gross profit margin is 54.10%

    Operating Profit

    -$14.22M
    CERS annual operating income is -$14.22 million

    Operating Margin

    -7.89%
    CERS annual operating profit margin is -7.89%

    Net Income

    -$20.96M
    CERS annual net profit is -$20.96 million

    Net Margin

    -11.60%
    CERS annual net profit margin is -11.60%

    Expenses

    Total Expenses

    $194.50M
    CERS annual total expenses is $194.50 million

    Operating Expenses

    $113.75M
    CERS annual total operating expenses is $113.75 million

    Cost Of Goods Sold

    $82.75M
    CERS annual cost of goods sold is $82.75 million

    Selling, General & Administrative Expenses

    $75.89M
    CERS annual SG&A is $75.89 million

    Depreciation & Amortization

    $1.85M
    CERS annual D&A is $1.85 million

    Interest Expense

    $0.00
    CERS annual interest expense is $0.00

    Income Tax

    $205.00K
    CERS annual income tax is $205.00 thousand

    EBIT & EBITDA

    EBIT

    -$14.22M
    CERS annual earnings before interest & taxes is -$14.22 million

    EBITDA

    -$14.22M
    CERS annual EBITDA is -$14.22 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $200.92M
    CERS annual total assets is $200.92 million

    Non Current Assets

    $48.90M
    CERS annual long term assets is $48.90 million

    Current Assets

    $152.02M
    CERS annual total current assets is $152.02 million

    Cash and Cash Equivalents

    $20.27M
    CERS annual cash & cash equivalents is $20.27 million

    Accounts Receivable

    $29.78M
    CERS annual accounts receivable is $29.78 million

    Inventory

    $38.15M
    CERS annual inventory is $38.15 million

    Liabilities

    Total Liabilities

    $144.02M
    CERS annual total liabilities is $144.02 million

    Long Term Liabilities

    $80.41M
    CERS annual total long term liabilities is $80.41 million

    Current Liabilities

    $63.61M
    CERS annual current liabilities is $63.61 million

    Accounts Payable

    $40.64M
    CERS annual accounts payable is $40.64 million

    Debt

    Total Debt

    $98.10M
    CERS annual total debt is $98.10 million

    Total Debt 1-Year Change

    +2.19%
    CERS annual total debt is up +2.19% year-on-year

    Long Term Debt

    $76.53M
    CERS annual long term debt is $76.53 million

    Short Term Debt

    $21.57M
    CERS annual short term debt is $21.57 million

    Equity & Capital

    Shareholders Equity

    $56.15M
    CERS annual stockholders equity is $56.15 million

    Book Value

    $56.15M
    CERS annual book value is $56.15 million

    Retained Earnings

    -$1.07B
    CERS annual retained earnings is -$1.07 billion

    Working Capital

    $88.41M
    CERS annual working capital is $88.41 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $11.36M
    CERS annual cash from operations is $11.36 million

    Cash From Operations 1-Year Change

    +126.31%
    CERS annual cash from operations is up +126.31% year-on-year

    Cash From Investing

    -$8.13M
    CERS annual cash from investing is -$8.13 million

    Cash From Investing 1-Year Change

    -194.27%
    CERS annual cash from investing is down -194.27% year-on-year

    Cash From Financing

    $4.96M
    CERS annual cash from financing is $4.96 million

    Cash From Financing 1-Year Change

    -53.49%
    CERS annual cash from financing is down -53.49% year-on-year

    CAPEX

    CAPEX

    $2.84M
    CERS annual capital expenditures is $2.84 million

    CAPEX 1-Year Change

    -38.29%
    CERS annual capital expenditures is down -38.29% year-on-year

    Free Cash Flow

    Free Cash Flow

    $8.52M
    CERS annual free cash flow is $8.52 million

    Free Cash Flow 1-Year Change

    +117.84%
    CERS annual free cash flow is up +117.84% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    54.10%
    CERS annual gross profit margin is 54.10%

    Operating Margin

    -7.89%
    CERS annual operating profit margin is -7.89%

    Net Margin

    -11.60%
    CERS annual net profit margin is -11.60%

    ROA & ROE

    ROA

    -10.52%
    CERS annual return on assets is -10.52%

    ROE

    -37.99%
    CERS annual return on equity is -37.99%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    CERS price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    CERS price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    6.81
    CERS price to book ratio is 6.81

    PB Ratio Sector Percentile

    82.08%
    CERS price to book ratio is higher than 82.08% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    2.10
    CERS price to sales ratio is 2.10

    PS Ratio Sector Percentile

    36.2%
    CERS price to sales ratio is higher than 36.2% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $438.42M
    CERS enterprise value is $438.42 million

    Enterprise Value Sector Percentile

    61.88%
    CERS enterprise value is higher than 61.88% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -12.85
    CERS EV/EBITDA is -12.85

    EV/EBITDA Sector Percentile

    11.72%
    CERS EV/EBITDA is higher than 11.72% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.39
    CERS annual current ratio is 2.39

    Quick Ratio

    1.79
    CERS annual quick ratio is 1.79

    Leverage

    Debt To Equity

    1.50
    CERS annual debt to equity ratio is 1.50

    Interest Coverage Ratio

    -
    CERS annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    4
    CERS piotroski f-score is 4

    Altman Z-Score

    -4.49
    CERS altman z-score is -4.49

    Analyst ratings

    Recent major analysts updates

    Feb 21, 25 Cantor Fitzgerald
    Overweight
    Oct 17, 24 Stifel
    Buy
    May 3, 24 Cantor Fitzgerald
    Overweight
    Apr 12, 24 Craig-Hallum
    Buy
    Mar 7, 24 Stephens & Co.
    Equal-Weight
    Mar 6, 24 Cantor Fitzgerald
    Overweight
    Jan 20, 23 BTIG
    Neutral
    May 27, 20 Stifel
    Buy
    Apr 16, 20 Stephens & Co.
    Overweight
    Feb 26, 20 BTIG Research
    Buy

    Institutional Ownership

    Screeners with CERS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Cerus Corporation?
    • Does Cerus Corporation pay dividends?
    • What sector is Cerus Corporation in?
    • What industry is Cerus Corporation in?
    • What country is Cerus Corporation based in?
    • When did Cerus Corporation go public?
    • Is Cerus Corporation in the S&P 500?
    • Is Cerus Corporation in the NASDAQ 100?
    • Is Cerus Corporation in the Dow Jones?
    • When was Cerus Corporation's last earnings report?
    • When does Cerus Corporation report earnings?

    What is the ticker symbol for Cerus Corporation?

    The ticker symbol for Cerus Corporation is NASDAQ:CERS

    Does Cerus Corporation pay dividends?

    No, Cerus Corporation does not pay dividends

    What sector is Cerus Corporation in?

    Cerus Corporation is in the Healthcare sector

    What industry is Cerus Corporation in?

    Cerus Corporation is in the Medical Devices industry

    What country is Cerus Corporation based in?

    Cerus Corporation is headquartered in United States

    When did Cerus Corporation go public?

    Cerus Corporation's initial public offering (IPO) was on January 31, 1997

    Is Cerus Corporation in the S&P 500?

    No, Cerus Corporation is not included in the S&P 500 index

    Is Cerus Corporation in the NASDAQ 100?

    No, Cerus Corporation is not included in the NASDAQ 100 index

    Is Cerus Corporation in the Dow Jones?

    No, Cerus Corporation is not included in the Dow Jones index

    When was Cerus Corporation's last earnings report?

    Cerus Corporation's most recent earnings report was on November 6, 2025

    When does Cerus Corporation report earnings?

    The next expected earnings date for Cerus Corporation is February 19, 2026
    On this page